News from aruvant sciences A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

May 11, 2020, 06:02 ET Aruvant Appoints Joseph McIntosh, M.D. as Chief Medical Officer

Aruvant, a clinical-stage biopharmaceutical company focused on developing and commercializing transformative therapies for the treatment of severe...


Jan 22, 2020, 08:00 ET Aruvant Receives Orphan Drug Designation for ARU-1801 for the Treatment of Sickle Cell Disease

Aruvant, a clinical-stage biopharmaceutical company focused on developing and commercializing transformative therapies for the treatment of severe...


Jan 08, 2020, 07:00 ET Aruvant Receives FDA Rare Pediatric Disease Designation for ARU-1801 for the Treatment of Sickle Cell Disease

Aruvant, a clinical-stage biopharmaceutical company focused on developing and commercializing transformative therapies for the treatment of severe...


Nov 19, 2019, 07:00 ET Aruvant Appoints William Chou as Chief Executive Officer

Aruvant, a clinical stage biopharmaceutical company focused on developing and commercializing transformative therapies for the treatment of severe...


Dec 03, 2018, 21:30 ET Aruvant Sciences Presents Data from Ongoing Clinical Study of Lentiviral Gene Therapy RVT-1801 for Sickle Cell Disease at 60th Annual Meeting of the American Society of Hematology

Aruvant Sciences, a clinical-stage gene therapy company focused on hematological conditions, today announced that preliminary safety and efficacy...